| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 1.23e-06 | 4 | 136 | 3 | GO:0004634 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB23 ABCC1 RAN KIF23 AK6 ATP8B1 ABCA10 ARF1 ARF3 ARF4 ARF5 LONP1 ABCA5 ARL13B NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 1.32e-06 | 775 | 136 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB23 ABCC1 RAN KIF23 AK6 ATP8B1 ABCA10 ARF1 ARF3 ARF4 ARF5 LONP1 ABCA5 ARL13B NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 4.20e-06 | 839 | 136 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB23 ABCC1 RAN KIF23 AK6 ATP8B1 ABCA10 ARF1 ARF3 ARF4 ARF5 LONP1 ABCA5 ARL13B NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 4.28e-06 | 840 | 136 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB23 ABCC1 RAN KIF23 AK6 ATP8B1 ABCA10 ARF1 ARF3 ARF4 ARF5 LONP1 ABCA5 ARL13B NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 4.28e-06 | 840 | 136 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | magnesium ion binding | 7.60e-06 | 247 | 136 | 10 | GO:0000287 | |
| GeneOntologyMolecularFunction | PH domain binding | 2.52e-05 | 9 | 136 | 3 | GO:0042731 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 KIF23 AK6 ATP8B1 ABCA10 LONP1 ABCA5 NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 4.98e-05 | 441 | 136 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.02e-05 | 196 | 136 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 1.38e-04 | 3 | 136 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 2.07e-04 | 43 | 136 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 KIF23 AK6 ATP8B1 ABCA10 ZRANB3 LONP1 ABCA5 NAV3 KIF14 KIF5B ABCD2 ATP2B1 | 2.95e-04 | 614 | 136 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 3.21e-04 | 316 | 136 | 9 | GO:0035091 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.44e-04 | 49 | 136 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 3.44e-04 | 49 | 136 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | phospholipid binding | OGT GLTP ESYT1 NCF4 ATP8B1 ACTN2 CPS1 KRIT1 SBF2 DAPP1 AKT1 PARD3 | 3.75e-04 | 548 | 136 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 4.34e-04 | 199 | 136 | 7 | GO:1901981 | |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 6.78e-04 | 6 | 136 | 2 | GO:0004694 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 9.02e-04 | 109 | 136 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 RAN OGT NCL ACTN2 XPO1 ARF1 AXIN1 LONP1 KIDINS220 KIF14 DMD KIT ATP2B1 EPB41L2 | 9.26e-04 | 875 | 136 | 15 | GO:0019904 |
| GeneOntologyMolecularFunction | microtubule binding | 1.25e-03 | 308 | 136 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.26e-03 | 8 | 136 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.64e-03 | 74 | 136 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SPEG HTATIP2 TSSK2 HKDC1 AK6 STK35 PDIK1L PRIM1 FLAD1 FAM20B NIM1K AKT1 PRKG2 TSSK3 KIT | 1.84e-03 | 938 | 136 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.00e-03 | 10 | 136 | 2 | GO:0140031 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | FLNA OGT ANK2 VPS26B LAMA5 ACTN2 ARL13B SEC16A AKT1 KIF5B PRKG2 EPB41L2 | 2.05e-05 | 422 | 134 | 12 | GO:1990778 |
| GeneOntologyBiologicalProcess | positive regulation of transport | TRIM46 SOX4 FLNA RAN ANK2 MYOM1 ICE1 ACTN2 DCX ADCY8 ARF1 ARRB1 ABCA5 AKT1 KIF5B EXOC2 DMD PARD3 NOS1 ATP2B1 | 2.23e-05 | 1081 | 134 | 20 | GO:0051050 |
| GeneOntologyCellularComponent | sarcomere | FLNA ANK2 MYOM1 MYOM3 ACTN2 NEB ARF1 FRG1 SPHKAP DMD ENO1 NOS1 | 7.94e-08 | 249 | 135 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | FLNA ANK2 MYOM1 MYOM3 ACTN2 NEB ARF1 FRG1 SPHKAP DMD ENO1 NOS1 | 2.15e-07 | 273 | 135 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | FLNA ANK2 MYOM1 MYOM3 ACTN2 NEB ARF1 FRG1 SPHKAP DMD ENO1 NOS1 | 4.11e-07 | 290 | 135 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 1.05e-06 | 4 | 135 | 3 | GO:0000015 | |
| GeneOntologyCellularComponent | Z disc | 6.28e-06 | 151 | 135 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.26e-05 | 166 | 135 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | M band | 4.57e-05 | 31 | 135 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SHANK1 FLNA OGT VPS26B LAMA5 GRIK3 ACTN2 BTBD9 DCX ADCY8 ARF1 ARF4 AKT1 NOS1 ATP2B1 CDH9 | 7.69e-05 | 817 | 135 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | Flemming body | 8.35e-05 | 36 | 135 | 4 | GO:0090543 | |
| GeneOntologyCellularComponent | postsynapse | SHANK1 FLNA OGT ANK2 VPS26B GRIK3 ACTN2 ELFN2 ADCY8 ARF1 ARF4 ARRB1 AKT1 KIF5B DMD NOS1 ATP2B1 CDH9 | 9.88e-05 | 1018 | 135 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | synaptic membrane | SHANK1 ANK2 GRIK3 ACTN2 ELFN2 ADCY8 ARRB1 SLC6A5 DMD ENO1 ENO2 ATP2B1 CDH9 | 1.06e-04 | 583 | 135 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | cell cortex | 1.52e-04 | 371 | 135 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | Cajal body | 2.14e-04 | 84 | 135 | 5 | GO:0015030 | |
| GeneOntologyCellularComponent | A band | 3.54e-04 | 52 | 135 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | endosome | RAB23 REP15 RAN ANK2 VPS26B SLC26A9 NCF4 NCL ARF1 SAMD9L ARRB1 KIDINS220 ABCA5 ACKR3 SBF2 SLC6A5 LRPAP1 RNF133 | 5.22e-04 | 1167 | 135 | 18 | GO:0005768 |
| GeneOntologyCellularComponent | supramolecular fiber | FLNA KIF23 ANK2 MYOM1 CAPN6 MYOM3 ACTN2 NEB DCX ARF1 FRG1 SPHKAP NAV3 KIF14 KIF5B DMD ENO1 NOS1 | 5.88e-04 | 1179 | 135 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.94e-04 | 523 | 135 | 11 | GO:0098984 | |
| GeneOntologyCellularComponent | supramolecular polymer | FLNA KIF23 ANK2 MYOM1 CAPN6 MYOM3 ACTN2 NEB DCX ARF1 FRG1 SPHKAP NAV3 KIF14 KIF5B DMD ENO1 NOS1 | 6.37e-04 | 1187 | 135 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | asymmetric synapse | 1.08e-03 | 477 | 135 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | myofilament | 1.14e-03 | 32 | 135 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | nuclear body | CENPB NOC3L TOPBP1 GEMIN5 AK6 ICE1 ATP8B1 XPO1 PIR STK35 NOP58 NAMPT ARRB1 FRG1 | 2.14e-03 | 903 | 135 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.19e-03 | 40 | 135 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | NSL complex | 2.19e-03 | 11 | 135 | 2 | GO:0044545 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SHANK1 FLNA OGT ACAD9 GRIK3 ACTN2 DCX ADCY8 ARF4 ARRB1 KIF5B DMD PARD3 ENO2 NOS1 ATP2B1 CDH9 | 2.40e-03 | 1228 | 135 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic density | 2.67e-03 | 451 | 135 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | FLNA REP15 PSMF1 ANK2 CAPN6 AXIN1 ARF3 ARF5 CCNT2 SBF2 SEC16A KIF5B DMD NOS1 | 2.90e-03 | 934 | 135 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | axonal growth cone | 3.07e-03 | 45 | 135 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | X chromosome | 3.08e-03 | 13 | 135 | 2 | GO:0000805 | |
| Domain | ARF | 5.28e-08 | 29 | 135 | 6 | PS51417 | |
| Domain | Arf | 8.09e-08 | 31 | 135 | 6 | PF00025 | |
| Domain | Small_GTPase_ARF/SAR | 1.20e-07 | 33 | 135 | 6 | IPR006689 | |
| Domain | Enolase_N | 3.69e-07 | 3 | 135 | 3 | PF03952 | |
| Domain | Enolase | 3.69e-07 | 3 | 135 | 3 | IPR000941 | |
| Domain | Enolase_C | 3.69e-07 | 3 | 135 | 3 | IPR020810 | |
| Domain | Enolase_N | 3.69e-07 | 3 | 135 | 3 | IPR020811 | |
| Domain | Enolase_CS | 3.69e-07 | 3 | 135 | 3 | IPR020809 | |
| Domain | Enolase_C | 3.69e-07 | 3 | 135 | 3 | PF00113 | |
| Domain | Enolase_N | 3.69e-07 | 3 | 135 | 3 | SM01193 | |
| Domain | Enolase_C | 3.69e-07 | 3 | 135 | 3 | SM01192 | |
| Domain | ENOLASE | 3.69e-07 | 3 | 135 | 3 | PS00164 | |
| Domain | P-loop_NTPase | RAB23 ABCC1 RAN NLRP12 KIF23 AK6 ABCA10 ZRANB3 ARF1 ARF3 ARF4 ARF5 LONP1 SAMD9L NWD2 ABCA5 ARL13B NAV3 KIF14 KIF5B ABCD2 | 7.54e-07 | 848 | 135 | 21 | IPR027417 |
| Domain | - | 1.47e-06 | 4 | 135 | 3 | 3.30.390.10 | |
| Domain | - | 1.47e-06 | 4 | 135 | 3 | 3.20.20.120 | |
| Domain | Enolase_C-like | 1.47e-06 | 4 | 135 | 3 | IPR029065 | |
| Domain | Enolase_N-like | 1.47e-06 | 4 | 135 | 3 | IPR029017 | |
| Domain | Small_GTPase_ARF | 1.89e-06 | 29 | 135 | 5 | IPR024156 | |
| Domain | - | RAB23 ABCC1 RAN NLRP12 AK6 ABCA10 ZRANB3 ARF1 ARF3 ARF4 ARF5 LONP1 SAMD9L NWD2 ABCA5 ARL13B NAV3 ABCD2 | 7.22e-06 | 746 | 135 | 18 | 3.40.50.300 |
| Domain | Small_GTP-bd_dom | 2.14e-04 | 167 | 135 | 7 | IPR005225 | |
| Domain | ABC_transporter_CS | 2.36e-04 | 42 | 135 | 4 | IPR017871 | |
| Domain | ABC_tran | 3.97e-04 | 48 | 135 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.97e-04 | 48 | 135 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.30e-04 | 49 | 135 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 4.65e-04 | 50 | 135 | 4 | IPR003439 | |
| Domain | ACTININ_2 | 5.88e-04 | 23 | 135 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.88e-04 | 23 | 135 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.88e-04 | 23 | 135 | 3 | IPR001589 | |
| Domain | AAA | 6.29e-04 | 144 | 135 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 6.29e-04 | 144 | 135 | 6 | IPR003593 | |
| Domain | Small_GTPase | 1.09e-03 | 160 | 135 | 6 | IPR001806 | |
| Domain | CH | 1.26e-03 | 65 | 135 | 4 | SM00033 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.57e-03 | 69 | 135 | 4 | IPR020636 | |
| Domain | CH | 1.66e-03 | 70 | 135 | 4 | PF00307 | |
| Domain | - | 1.74e-03 | 71 | 135 | 4 | 1.10.418.10 | |
| Domain | Protein_kinase_ATP_BS | 1.76e-03 | 379 | 135 | 9 | IPR017441 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_TRANSPORT | 2.19e-05 | 8 | 105 | 3 | M48263 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_TRANSPORT | 2.19e-05 | 8 | 105 | 3 | MM17237 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 8.94e-05 | 98 | 105 | 6 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.00e-04 | 100 | 105 | 6 | M27650 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 PSMF1 GLTP ESYT1 SLC38A4 SLC26A9 ATP8B1 ABCA10 ADCY8 ARF1 ABCA5 SLC6A5 TRPM8 ABCD2 ATP2B1 ANO3 | 1.04e-04 | 736 | 105 | 16 | M27287 |
| Pubmed | SHANK1 TRIM46 SIN3B RAN KIF23 OGT ANK2 TBL1Y NCL GRIK3 BTBD9 DCX ARF3 ARF5 SPHKAP SEC16A MIOS KIF5B PARD3 ENO1 NOS1 EPB41L2 | 4.28e-11 | 963 | 139 | 22 | 28671696 | |
| Pubmed | ABCC1 FLNA RAN PSMF1 ESYT1 HTATIP2 GEMIN5 AK6 NCL XPO1 RETSAT ARF4 LONP1 NOP58 KIDINS220 PRIM1 MARF1 KIF14 KIF5B NUP188 EXOC2 ENO1 ATP2B1 | 2.73e-10 | 1168 | 139 | 23 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA RAN KIF23 MAT2B ACAD9 ESYT1 NOC3L GEMIN5 DUOX2 NCL XPO1 ARF1 ARF4 LONP1 NOP58 NAMPT KIDINS220 PRIM1 KIF14 KIF5B NUP188 EMC2 ENO1 ATP2B1 EPB41L2 | 4.57e-10 | 1425 | 139 | 25 | 30948266 |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 1.22e-09 | 5 | 139 | 4 | 2105501 | |
| Pubmed | FLNA RAN KIF23 DCUN1D5 CENPB ACAD9 ESYT1 LAMA5 GEMIN5 NCL XPO1 PIR RETSAT ARF1 ARF4 KIDINS220 FADS3 GCLM RIMOC1 LRPAP1 NUP188 CNOT3 EPB41L2 | 2.03e-09 | 1297 | 139 | 23 | 33545068 | |
| Pubmed | SHANK1 TRIM46 FLNA RAN OGT ANK2 GEMIN5 NCL ACTN2 XPO1 ELFN2 ARF4 ARF5 LONP1 NWD2 KIDINS220 SEC16A MIOS KIF5B DMD ENO2 NOS1 ATP2B1 EPB41L2 | 2.59e-09 | 1431 | 139 | 24 | 37142655 | |
| Pubmed | ABCC1 FLNA RAN KIF23 CENPB ACAD9 ESYT1 NOC3L GEMIN5 AK6 XPO1 NKRF ARF4 LONP1 NOP58 NAMPT KIF14 NUP188 EXOC2 EMC2 ENO1 ATP2B1 CNOT3 | 1.43e-08 | 1440 | 139 | 23 | 30833792 | |
| Pubmed | 1.69e-08 | 8 | 139 | 4 | 8947846 | ||
| Pubmed | 1.69e-08 | 8 | 139 | 4 | 8195219 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA RAN OGT MAT2B GEMIN5 NCL XPO1 CPS1 ARF1 ARF4 LONP1 NOP58 NAMPT ARRB1 GCLM FRG1 SEC16A KIF5B EXOC2 EMC2 ENO1 EPB41L2 | 4.94e-08 | 1415 | 139 | 22 | 28515276 |
| Pubmed | 5.04e-08 | 10 | 139 | 4 | 10828067 | ||
| Pubmed | FLNA KIF23 NOC3L GEMIN5 NCL XPO1 NKRF ARF3 LONP1 NOP58 SEC16A KIF14 KIF5B NUP188 EPB41L2 | 6.19e-08 | 653 | 139 | 15 | 22586326 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23783033 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 1447192 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 28762597 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ABCC1 FLNA RAN ACAD9 ESYT1 SPEG LAMA5 HKDC1 NCL XPO1 AXIN1 ARF3 ARF4 ARF5 LONP1 FADS3 SEC16A LRPAP1 AKT1 EMC2 ATP2B1 EPB41L2 | 7.64e-08 | 1451 | 139 | 22 | 30550785 |
| Pubmed | RAB23 RAN KIF23 ESYT1 NOC3L NCL ARF1 ARF3 ARF4 ARF5 KIDINS220 ARL13B SEC16A PARD3 ANO3 EPB41L2 | 9.75e-08 | 777 | 139 | 16 | 35844135 | |
| Pubmed | ABCC1 FLNA RAN GLTP ESYT1 NCL XPO1 RETSAT ARF4 LONP1 NOP58 GCLM KIF5B C9 ENO1 | 1.85e-07 | 711 | 139 | 15 | 33022573 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 10090150 | ||
| Pubmed | Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. | 2.49e-07 | 4 | 139 | 3 | 16902413 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 8491770 | ||
| Pubmed | A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA. | 2.49e-07 | 4 | 139 | 3 | 25918939 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA RAN OGT ESYT1 NOC3L GEMIN5 AK6 NCL NKRF ARF3 ARF4 ARF5 LONP1 NOP58 NAMPT GCLM FRG1 SEC16A ENO1 LRIF1 | 3.15e-07 | 1318 | 139 | 20 | 30463901 |
| Pubmed | 3.28e-07 | 163 | 139 | 8 | 16512683 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA RAN KIF23 ESYT1 NOC3L GEMIN5 NCL XPO1 NKRF ARF4 LONP1 NOP58 NAMPT SEC16A KIF5B EXOC2 PARD3 ENO1 ATP2B1 EPB41L2 | 4.75e-07 | 1353 | 139 | 20 | 29467282 |
| Pubmed | SIN3B OGT TBL1Y ACAD9 ESYT1 NOC3L TOPBP1 LAMA5 GEMIN5 ICE1 NKRF ARRB1 KIDINS220 ACKR3 FRG1 MIOS KIF14 EXOC2 PARD3 CNOT3 EPB41L2 | 5.57e-07 | 1497 | 139 | 21 | 31527615 | |
| Pubmed | 5.95e-07 | 241 | 139 | 9 | 23125841 | ||
| Pubmed | Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. | 6.04e-07 | 121 | 139 | 7 | 8827514 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 9038142 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA SIN3B KIF23 ESYT1 GEMIN5 KIDINS220 SEC16A KIF5B EPB41L2 | 9.83e-07 | 256 | 139 | 9 | 33397691 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.05e-06 | 190 | 139 | 8 | 15161933 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA SIN3B RAN KIF23 ANK2 ESYT1 NOC3L GEMIN5 NCL ICE1 NKRF NAMPT SEC16A KIF5B ENO1 EPB41L2 | 1.12e-06 | 934 | 139 | 16 | 33916271 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | ACAD9 ESYT1 XPO1 CPS1 LONP1 NOP58 KIDINS220 EMC2 ENO1 ATP2B1 ENO3 | 1.15e-06 | 422 | 139 | 11 | 27342126 |
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 1.24e-06 | 6 | 139 | 3 | 33443570 | |
| Pubmed | WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. | 1.24e-06 | 6 | 139 | 3 | 24768165 | |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 19433310 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 FLNA ESYT1 NOC3L GEMIN5 NCL XPO1 AXIN1 ARF5 CCNT2 NOP58 FADS3 RRN3 FAM20B LRPAP1 NUP188 ENO1 ATP2B1 | 1.58e-06 | 1203 | 139 | 18 | 29180619 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CFAP251 KIF23 MYOM1 GEMIN5 NCL ICE1 SAMD9L TCEANC2 KIF14 ENO1 | 2.09e-06 | 361 | 139 | 10 | 26167880 |
| Pubmed | Identification of a new Pyk2 target protein with Arf-GAP activity. | 2.16e-06 | 7 | 139 | 3 | 10022920 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 11950392 | ||
| Pubmed | FLNA SIN3B KIF23 OGT GEMIN5 NKRF NOP58 SEC16A KIF14 KIF5B PARD3 ENO1 | 2.30e-06 | 549 | 139 | 12 | 38280479 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA SIN3B RAN PSMF1 KIF23 ESYT1 NOC3L GEMIN5 AK6 NCL XPO1 PIR ARF3 ARF4 NOP58 NAMPT SEC16A KIF5B ENO1 | 2.33e-06 | 1367 | 139 | 19 | 32687490 |
| Pubmed | FLNA RAN KIF23 OGT NCL XPO1 NKRF ARF1 AXIN1 ARF4 CCNT2 LONP1 NOP58 SEC16A KIF5B PARD3 ENO1 CNOT3 | 2.62e-06 | 1247 | 139 | 18 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAN OGT ESYT1 AK6 NCL XPO1 NKRF ARF1 ARF3 ARF4 ARF5 NOP58 NAMPT GCLM SEC16A KIF5B NUP188 ENO1 | 2.92e-06 | 1257 | 139 | 18 | 37317656 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | HKDC1 NCL ACTN2 XPO1 ARF1 ARF4 ARF5 LONP1 NOP58 NAMPT ENO2 ENO3 CNOT3 | 2.92e-06 | 665 | 139 | 13 | 30457570 |
| Pubmed | ABCC1 FLNA RAN NCL ARF1 ARF3 ARF4 NAMPT ENO1 ENO2 ATP2B1 EPB41L2 | 3.09e-06 | 565 | 139 | 12 | 20458337 | |
| Pubmed | SHANK1 FLNA ANK2 NCL ELFN2 ARF4 ARF5 LONP1 NAMPT SPHKAP NAV3 KIF5B EMC2 ENO1 NOS1 CNOT3 EPB41L2 | 3.26e-06 | 1139 | 139 | 17 | 36417873 | |
| Pubmed | Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol. | 3.45e-06 | 8 | 139 | 3 | 8355790 | |
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 3.45e-06 | 8 | 139 | 3 | 20215401 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA RAN NCL XPO1 NKRF ARF1 LONP1 NOP58 SEC16A KIF14 KIF5B NUP188 EMC2 ENO1 ATP2B1 EPB41L2 | 3.64e-06 | 1024 | 139 | 16 | 24711643 |
| Pubmed | ABCC1 FLNA RAN ESYT1 NCL XPO1 AXIN1 NOP58 KIDINS220 NUP188 EPB41L2 | 4.27e-06 | 484 | 139 | 11 | 31995728 | |
| Pubmed | SHANK1 FLNA PNLIP NCL NEB ARRB1 NAV3 LRPAP1 KIF5B DMD EPB41L2 | 4.45e-06 | 486 | 139 | 11 | 20936779 | |
| Pubmed | FLNA RAN ESYT1 NOC3L LAMA5 NCL XPO1 ARF4 ARF5 NOP58 GCLM KIF5B ENO1 ENO2 | 4.47e-06 | 803 | 139 | 14 | 36517590 | |
| Pubmed | 4.90e-06 | 491 | 139 | 11 | 22623428 | ||
| Pubmed | FLNA RAN ANK2 NOC3L HKDC1 DUOX2 REL NCL ACTN2 NEB RNF17 ARRB1 MARF1 KIF5B DMD EMC2 ENO1 ATP2B1 DNMT3B | 5.04e-06 | 1442 | 139 | 19 | 35575683 | |
| Pubmed | 5.19e-06 | 494 | 139 | 11 | 26831064 | ||
| Pubmed | 5.53e-06 | 63 | 139 | 5 | 11572484 | ||
| Pubmed | RAN ANK2 ESYT1 XPO1 ARF3 KIDINS220 GCLM SEC16A KIF5B PARD3 ENO1 ATP2B1 EPB41L2 | 5.75e-06 | 708 | 139 | 13 | 39231216 | |
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 6.56e-06 | 173 | 139 | 7 | 22119785 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 7.34e-06 | 10 | 139 | 3 | 20368620 | |
| Pubmed | TRIM46 SOX4 PINLYP ANK2 DCUN1D5 REL CPS1 ARF5 SMYD4 GCLM TYW5 RIMOC1 MARF1 KIF14 AKT1 NUP188 KIT | 7.63e-06 | 1215 | 139 | 17 | 15146197 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.16e-06 | 332 | 139 | 9 | 32786267 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA RAN OGT VPS26B ACAD9 ESYT1 NCL XPO1 KIDINS220 FLAD1 SEC16A RIMOC1 NUP188 DMD ATP2B1 | 8.88e-06 | 974 | 139 | 15 | 28675297 |
| Pubmed | FLNA RAN ANK2 ESYT1 NCL NKRF ARF1 ARF4 NOP58 NAMPT GCLM FRG1 SEC16A MARF1 KIF5B PARD3 ENO1 EPB41L2 | 9.59e-06 | 1371 | 139 | 18 | 36244648 | |
| Pubmed | FLNA RAN MAT2B ACAD9 GEMIN5 XPO1 LONP1 NUP188 ENO1 ATP2B1 EPB41L2 | 1.08e-05 | 534 | 139 | 11 | 35032548 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.08e-05 | 344 | 139 | 9 | 30333137 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA RAN KIF23 ESYT1 NOC3L NCL XPO1 NKRF ARF4 NOP58 FRG1 PRIM1 KIF14 KIF5B C9 ENO1 EPB41L2 | 1.18e-05 | 1257 | 139 | 17 | 36526897 |
| Pubmed | ABCC1 FLNA RAN DCUN1D5 ACAD9 ESYT1 NCL XPO1 ARF4 LONP1 FLAD1 ENO1 ATP2B1 EPB41L2 | 1.22e-05 | 878 | 139 | 14 | 37223481 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | TMEM169 SPEG C2orf15 NCL XPO1 RETSAT CCNT2 ACKR3 GPR75 LRPAP1 | 1.23e-05 | 442 | 139 | 10 | 15815621 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNA OGT CENPB ACAD9 NOC3L ICE1 BTBD9 ARF4 LONP1 RRN3 FRG1 PRIM1 MIOS KIF5B NUP188 | 1.28e-05 | 1005 | 139 | 15 | 19615732 |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 1.34e-05 | 12 | 139 | 3 | 8618961 | |
| Pubmed | 1.34e-05 | 12 | 139 | 3 | 30631079 | ||
| Pubmed | FLNA ANK2 ESYT1 XPO1 ARF3 KIDINS220 SEC16A KIF5B EMC2 EPB41L2 | 1.41e-05 | 449 | 139 | 10 | 31732153 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.43e-05 | 195 | 139 | 7 | 17110338 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.43e-05 | 271 | 139 | 8 | 25737280 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24486332 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9536086 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29104511 | ||
| Pubmed | Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. | 1.59e-05 | 2 | 139 | 2 | 1899243 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12134013 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32367034 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11268022 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24063785 | ||
| Pubmed | The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. | 1.59e-05 | 2 | 139 | 2 | 9837918 | |
| Pubmed | Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. | 1.59e-05 | 2 | 139 | 2 | 9681470 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32585100 | ||
| Pubmed | Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart. | 1.59e-05 | 2 | 139 | 2 | 34068508 | |
| Pubmed | HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages. | 1.59e-05 | 2 | 139 | 2 | 17922513 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22952904 | ||
| Pubmed | Akt is involved in the inhibition of cell proliferation by EGF. | 1.59e-05 | 2 | 139 | 2 | 17934337 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35864964 | ||
| Pubmed | The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA. | 1.59e-05 | 2 | 139 | 2 | 25486595 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25486594 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15574331 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 1577740 | ||
| Pubmed | Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle. | 1.59e-05 | 2 | 139 | 2 | 26604149 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8661066 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20410290 | ||
| Pubmed | NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction. | 1.59e-05 | 2 | 139 | 2 | 22251423 | |
| Pubmed | Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17. | 1.59e-05 | 2 | 139 | 2 | 26378238 | |
| Interaction | ARF6 interactions | RAB23 ABCC1 KIF23 ESYT1 ARF1 KRIT1 ARF4 ARF5 LONP1 NAMPT ARRB1 ARL13B DMD PARD3 ATP2B1 EPB41L2 | 2.12e-06 | 584 | 136 | 16 | int:ARF6 |
| Interaction | KCTD13 interactions | SHANK1 TRIM46 FLNA RAN OGT ANK2 GEMIN5 NCL ACTN2 XPO1 BTBD9 ELFN2 ARF4 ARF5 LONP1 NWD2 KIDINS220 SEC16A MIOS KIF5B DMD ENO2 NOS1 ATP2B1 EPB41L2 | 6.18e-06 | 1394 | 136 | 25 | int:KCTD13 |
| Interaction | C11orf52 interactions | RAB23 ABCC1 ESYT1 XPO1 ARF1 LONP1 KIDINS220 ARL13B PARD3 ATP2B1 EPB41L2 | 8.71e-06 | 311 | 136 | 11 | int:C11orf52 |
| Interaction | DENND1B interactions | 1.09e-05 | 21 | 136 | 4 | int:DENND1B | |
| Interaction | PHLPP1 interactions | FLNA SIN3B KIF23 ESYT1 GEMIN5 NEB KIDINS220 SEC16A AKT1 KIF5B EPB41L2 | 1.65e-05 | 333 | 136 | 11 | int:PHLPP1 |
| Interaction | CLK1 interactions | 1.82e-05 | 219 | 136 | 9 | int:CLK1 | |
| Interaction | ARHGAP21 interactions | 2.10e-05 | 223 | 136 | 9 | int:ARHGAP21 | |
| Interaction | PEX3 interactions | 2.14e-05 | 171 | 136 | 8 | int:PEX3 | |
| Interaction | POLR1E interactions | 2.61e-05 | 350 | 136 | 11 | int:POLR1E | |
| Interaction | POLR1G interactions | OGT NOC3L TOPBP1 REL NCL ICE1 XPO1 NKRF ARF4 NOP58 ARRB1 RRN3 NUP188 | 2.77e-05 | 489 | 136 | 13 | int:POLR1G |
| Interaction | AP4E1 interactions | 3.15e-05 | 54 | 136 | 5 | int:AP4E1 | |
| Interaction | TTN interactions | 3.64e-05 | 299 | 136 | 10 | int:TTN | |
| Interaction | PDK4 interactions | 3.77e-05 | 56 | 136 | 5 | int:PDK4 | |
| Interaction | RND1 interactions | 4.53e-05 | 246 | 136 | 9 | int:RND1 | |
| Interaction | RICTOR interactions | FLNA KIF23 DCUN1D5 XPO1 CPS1 ARF1 ARF3 ARF5 LONP1 SEC16A KIF14 AKT1 KIF5B ENO1 ATP2B1 EPB41L2 | 5.42e-05 | 759 | 136 | 16 | int:RICTOR |
| Interaction | ETFB interactions | 5.63e-05 | 253 | 136 | 9 | int:ETFB | |
| Interaction | AHNAK interactions | 6.11e-05 | 318 | 136 | 10 | int:AHNAK | |
| Interaction | FKBP1B interactions | 6.16e-05 | 32 | 136 | 4 | int:FKBP1B | |
| Interaction | CDC73 interactions | FLNA RAN NCL ACTN2 XPO1 ARF1 ARF3 ARF4 KIDINS220 ENO1 DNMT3B | 6.33e-05 | 386 | 136 | 11 | int:CDC73 |
| Interaction | ARFIP2 interactions | 7.46e-05 | 104 | 136 | 6 | int:ARFIP2 | |
| Interaction | SOX2 interactions | FLNA SIN3B RAN KIF23 OGT NOC3L NCL XPO1 NKRF ARF3 ARF4 LONP1 NOP58 KIDINS220 FLAD1 SEC16A MARF1 NAV3 KIF14 AKT1 ENO1 NOS1 CNOT3 | 7.69e-05 | 1422 | 136 | 23 | int:SOX2 |
| Interaction | CLINT1 interactions | 8.28e-05 | 207 | 136 | 8 | int:CLINT1 | |
| Interaction | BIRC3 interactions | FLNA RAN KIF23 MAT2B ACAD9 ESYT1 GEMIN5 DUOX2 REL NCL XPO1 ARF1 ARF4 LONP1 NOP58 NAMPT KIF5B NUP188 EMC2 ENO1 ATP2B1 EPB41L2 | 8.47e-05 | 1334 | 136 | 22 | int:BIRC3 |
| Interaction | PTPN1 interactions | FLNA TMEM169 DCUN1D5 ESYT1 GEMIN5 ARF1 ARF4 KIDINS220 FLAD1 SEC16A KIF14 AKT1 KIF5B EMC2 | 8.63e-05 | 625 | 136 | 14 | int:PTPN1 |
| Interaction | FOXO4 interactions | 8.83e-05 | 35 | 136 | 4 | int:FOXO4 | |
| Interaction | OTOA interactions | 1.04e-04 | 14 | 136 | 3 | int:OTOA | |
| Interaction | G6PD interactions | 1.04e-04 | 214 | 136 | 8 | int:G6PD | |
| Interaction | LYN interactions | RAB23 ABCC1 KIF23 ANK2 ESYT1 ARF1 KIDINS220 ARL13B DAPP1 KIF14 DMD PARD3 KIT ATP2B1 EPB41L2 | 1.07e-04 | 720 | 136 | 15 | int:LYN |
| Interaction | ZC3H7A interactions | 1.08e-04 | 215 | 136 | 8 | int:ZC3H7A | |
| Interaction | LAMTOR1 interactions | RAB23 ABCC1 ARF1 AXIN1 ARF3 ARF4 ARF5 LONP1 NAMPT KIDINS220 ARL13B DMD PARD3 ATP2B1 EPB41L2 | 1.11e-04 | 722 | 136 | 15 | int:LAMTOR1 |
| Interaction | CFD interactions | ABCC1 FLNA RAN ACAD9 ESYT1 SPEG LAMA5 HKDC1 NCL XPO1 AXIN1 ARF3 ARF4 ARF5 LONP1 FADS3 SEC16A LRPAP1 AKT1 EMC2 ATP2B1 EPB41L2 | 1.12e-04 | 1360 | 136 | 22 | int:CFD |
| Interaction | ARF3 interactions | 1.21e-04 | 163 | 136 | 7 | int:ARF3 | |
| Interaction | FNDC5 interactions | ABCC1 FLNA RAN GLTP ACAD9 ESYT1 SPEG LAMA5 HKDC1 NCL XPO1 AXIN1 ARF3 ARF4 ARF5 LONP1 FADS3 SEC16A LRPAP1 AKT1 EMC2 ATP2B1 EPB41L2 | 1.26e-04 | 1470 | 136 | 23 | int:FNDC5 |
| Interaction | PIH1D1 interactions | FLNA RAN OGT MAT2B GEMIN5 NCL XPO1 CPS1 ARF4 LONP1 NOP58 GCLM SBF2 SEC16A ENO1 | 1.27e-04 | 731 | 136 | 15 | int:PIH1D1 |
| Interaction | IMPDH2 interactions | FLNA KIF23 OGT HTATIP2 GEMIN5 ARF1 SEC16A KIF14 AKT1 KIF5B EMC2 | 1.34e-04 | 420 | 136 | 11 | int:IMPDH2 |
| Interaction | RAB35 interactions | ABCC1 ESYT1 ARF1 KRIT1 ARF4 KIDINS220 SBF2 ARL13B SLC6A5 KIF14 PARD3 ATP2B1 EPB41L2 | 1.38e-04 | 573 | 136 | 13 | int:RAB35 |
| Interaction | YAP1 interactions | FLNA SIN3B RAN OGT ACAD9 GEMIN5 NCL XPO1 NKRF AXIN1 SEC16A KIF14 AKT1 KIF5B PARD3 ENO1 ENO2 ENO3 EPB41L2 | 1.42e-04 | 1095 | 136 | 19 | int:YAP1 |
| Interaction | TNFAIP1 interactions | 1.44e-04 | 74 | 136 | 5 | int:TNFAIP1 | |
| Interaction | STIP1 interactions | FLNA RAN OGT ESYT1 TSSK2 GEMIN5 XPO1 NEB NKRF LONP1 NOP58 NAMPT NUP188 ENO1 ENO2 ENO3 ANO3 EPB41L2 | 1.48e-04 | 1006 | 136 | 18 | int:STIP1 |
| Interaction | OCLN interactions | ABCC1 OGT ANK2 ACAD9 ARF3 ARF5 KIDINS220 ARL13B KIF14 PARD3 ATP2B1 EPB41L2 | 1.49e-04 | 500 | 136 | 12 | int:OCLN |
| Interaction | MYPN interactions | 1.50e-04 | 40 | 136 | 4 | int:MYPN | |
| Interaction | WDR5 interactions | ABCC1 FLNA RAN KIF23 OGT GLTP ESYT1 NCL XPO1 RETSAT ARF4 LONP1 NOP58 GCLM MARF1 KIF5B C9 ENO1 LRIF1 | 1.52e-04 | 1101 | 136 | 19 | int:WDR5 |
| Interaction | SIRT7 interactions | FLNA KIF23 NOC3L GEMIN5 NCL XPO1 NKRF ARF3 LONP1 NOP58 SEC16A KIF14 KIF5B NUP188 EPB41L2 | 1.54e-04 | 744 | 136 | 15 | int:SIRT7 |
| Interaction | RAB3D interactions | 1.66e-04 | 41 | 136 | 4 | int:RAB3D | |
| Interaction | RHOC interactions | RAB23 ABCC1 RAN KIF23 ESYT1 KRIT1 LONP1 KIDINS220 ARL13B KIF14 EMC2 PARD3 ATP2B1 | 1.66e-04 | 584 | 136 | 13 | int:RHOC |
| Interaction | HSD17B10 interactions | KIF23 GLTP ACAD9 CPS1 LONP1 NOP58 NAMPT KIF14 ENO1 ENO2 ENO3 | 1.78e-04 | 434 | 136 | 11 | int:HSD17B10 |
| Interaction | AURKB interactions | FLNA KIF23 OGT AK6 XPO1 CPS1 ARF3 ARF4 LONP1 NOP58 NIM1K SEC16A KIF14 KIF5B NUP188 | 1.96e-04 | 761 | 136 | 15 | int:AURKB |
| Interaction | AP2A1 interactions | 1.99e-04 | 299 | 136 | 9 | int:AP2A1 | |
| Interaction | SMN1 interactions | 1.99e-04 | 299 | 136 | 9 | int:SMN1 | |
| Interaction | KIF23 interactions | FLNA RAN KIF23 ESYT1 NOC3L HKDC1 NCL XPO1 CPS1 NKRF ARF3 ARF4 ARF5 LONP1 NOP58 KIF14 DMD ENO1 | 2.00e-04 | 1031 | 136 | 18 | int:KIF23 |
| Interaction | SEC31A interactions | 2.04e-04 | 236 | 136 | 8 | int:SEC31A | |
| Interaction | SUMO3 interactions | 2.15e-04 | 126 | 136 | 6 | int:SUMO3 | |
| Interaction | GAPDH interactions | FLNA RAN KIF23 OGT MAT2B VPS26B NCL SAMD9L KIF14 AKT1 EMC2 ENO1 ENO2 ENO3 | 2.27e-04 | 686 | 136 | 14 | int:GAPDH |
| Interaction | SYNGAP1 interactions | 2.43e-04 | 307 | 136 | 9 | int:SYNGAP1 | |
| Interaction | KIF20A interactions | FLNA KIF23 ANK2 CENPB NOC3L NCL ACTN2 XPO1 CPS1 LONP1 NOP58 SAMD9L KIDINS220 SEC16A NAV3 KIF14 PARD3 CDH9 | 2.56e-04 | 1052 | 136 | 18 | int:KIF20A |
| Interaction | AP3B1 interactions | 2.82e-04 | 187 | 136 | 7 | int:AP3B1 | |
| Interaction | RAC1 interactions | RAB23 ABCC1 FLNA RAN ESYT1 NCL XPO1 ELFN2 KRIT1 ARF5 LONP1 KIDINS220 ARL13B KIF14 AKT1 EMC2 PARD3 ATP2B1 | 2.90e-04 | 1063 | 136 | 18 | int:RAC1 |
| Interaction | ENTR1 interactions | 2.92e-04 | 188 | 136 | 7 | int:ENTR1 | |
| Interaction | C1orf174 interactions | 3.07e-04 | 48 | 136 | 4 | int:C1orf174 | |
| Interaction | TNS3 interactions | 3.08e-04 | 87 | 136 | 5 | int:TNS3 | |
| Interaction | NME2 interactions | 3.11e-04 | 190 | 136 | 7 | int:NME2 | |
| Interaction | APC interactions | 3.15e-04 | 389 | 136 | 10 | int:APC | |
| Interaction | SLC31A1 interactions | 3.31e-04 | 192 | 136 | 7 | int:SLC31A1 | |
| Interaction | LDHAL6B interactions | 3.32e-04 | 49 | 136 | 4 | int:LDHAL6B | |
| Interaction | CSNK1D interactions | 3.35e-04 | 254 | 136 | 8 | int:CSNK1D | |
| Interaction | NCKIPSD interactions | 3.37e-04 | 137 | 136 | 6 | int:NCKIPSD | |
| Interaction | KIAA0319L interactions | 3.61e-04 | 90 | 136 | 5 | int:KIAA0319L | |
| Interaction | MYOT interactions | 3.66e-04 | 21 | 136 | 3 | int:MYOT | |
| Interaction | COIL interactions | KIF23 OGT ICE1 ACTN2 XPO1 ARF4 LONP1 NOP58 NAMPT FRG1 KIF14 NUP188 | 3.69e-04 | 552 | 136 | 12 | int:COIL |
| Interaction | FLOT1 interactions | ABCC1 FLNA KIF23 ANK2 KIDINS220 ARL13B KIF14 NUP188 PARD3 ATP2B1 EPB41L2 | 3.84e-04 | 475 | 136 | 11 | int:FLOT1 |
| Interaction | RRM1 interactions | 3.93e-04 | 141 | 136 | 6 | int:RRM1 | |
| Interaction | AP3S1 interactions | 3.93e-04 | 141 | 136 | 6 | int:AP3S1 | |
| Interaction | DMD interactions | 3.93e-04 | 141 | 136 | 6 | int:DMD | |
| Interaction | FBXO25 interactions | 3.99e-04 | 198 | 136 | 7 | int:FBXO25 | |
| Interaction | CHMP4B interactions | FLNA KIF23 VPS26B ESYT1 NCL ACTN2 CPS1 ARF1 ARF4 ARF5 LONP1 KIDINS220 KIF14 ENO1 | 4.08e-04 | 727 | 136 | 14 | int:CHMP4B |
| Interaction | RCC1 interactions | 4.36e-04 | 201 | 136 | 7 | int:RCC1 | |
| Interaction | ASH2L interactions | 4.44e-04 | 265 | 136 | 8 | int:ASH2L | |
| Interaction | ANO2 interactions | 4.46e-04 | 5 | 136 | 2 | int:ANO2 | |
| Interaction | COPE interactions | 4.49e-04 | 334 | 136 | 9 | int:COPE | |
| Interaction | CAPN6 interactions | 4.82e-04 | 23 | 136 | 3 | int:CAPN6 | |
| Interaction | SLX4 interactions | FLNA RAN KIF23 OGT CENPB TOPBP1 NCL NKRF NOP58 NUP188 ENO1 LRIF1 | 5.06e-04 | 572 | 136 | 12 | int:SLX4 |
| Cytoband | 4q25-q27 | 9.10e-06 | 2 | 139 | 2 | 4q25-q27 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 9.78e-09 | 31 | 92 | 6 | 357 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 7.03e-04 | 8 | 92 | 2 | 658 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.65e-03 | 46 | 92 | 3 | 622 | |
| GeneFamily | ATP binding cassette subfamily A | 2.24e-03 | 14 | 92 | 2 | 805 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN | 1.20e-05 | 200 | 139 | 8 | M6634 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP | 1.20e-05 | 200 | 139 | 8 | M9060 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.69e-05 | 349 | 137 | 11 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 2.73e-05 | 241 | 137 | 9 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.52e-05 | 378 | 137 | 11 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | SOX4 KIF23 MYOM1 PHTF2 ZRANB3 NOP58 PRIM1 DAPP1 KIF14 KIT DNMT3B | 9.64e-05 | 423 | 137 | 11 | GSM791126_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | SOX4 KIF23 PNLIP CENPB CAPN6 NCL ARF1 ARF4 AKT1 CNOT3 EPB41L2 | 1.23e-04 | 435 | 137 | 11 | gudmap_developingGonad_e11.5_testes and mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.24e-04 | 362 | 137 | 10 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | SOX4 KIF23 PNLIP CENPB CAPN6 NCL ARF1 ARF4 AKT1 CNOT3 EPB41L2 | 1.28e-04 | 437 | 137 | 11 | gudmap_developingGonad_e11.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.30e-04 | 231 | 137 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 1.41e-07 | 188 | 139 | 8 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.49e-07 | 149 | 139 | 7 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.06e-06 | 187 | 139 | 7 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 190 | 139 | 7 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 190 | 139 | 7 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 190 | 139 | 7 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-06 | 195 | 139 | 7 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.81e-06 | 196 | 139 | 7 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.00e-05 | 157 | 139 | 6 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 162 | 139 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 175 | 139 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 176 | 139 | 6 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 176 | 139 | 6 | bfea433544c6d6b8ad55e50ca94c5574460c2e0b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 176 | 139 | 6 | 3c78dee7e1111a579fde6d401b9ecb4d5b8e782f | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 179 | 139 | 6 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 179 | 139 | 6 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 181 | 139 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 181 | 139 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-05 | 182 | 139 | 6 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 2.32e-05 | 182 | 139 | 6 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 2.32e-05 | 182 | 139 | 6 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 182 | 139 | 6 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.32e-05 | 182 | 139 | 6 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 182 | 139 | 6 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 182 | 139 | 6 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.32e-05 | 182 | 139 | 6 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 109 | 139 | 5 | e8e0f2c5f8c9e45f2b4d173569c94275eedfe432 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 184 | 139 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 184 | 139 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 185 | 139 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 2.54e-05 | 185 | 139 | 6 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.54e-05 | 185 | 139 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 185 | 139 | 6 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 185 | 139 | 6 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 185 | 139 | 6 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-05 | 186 | 139 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 2.70e-05 | 187 | 139 | 6 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | CD8+_Memory_T_cell-CV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.70e-05 | 187 | 139 | 6 | 9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.78e-05 | 188 | 139 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 188 | 139 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.78e-05 | 188 | 139 | 6 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-05 | 113 | 139 | 5 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.87e-05 | 189 | 139 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 2.87e-05 | 189 | 139 | 6 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.95e-05 | 190 | 139 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 190 | 139 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.95e-05 | 190 | 139 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.04e-05 | 191 | 139 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 3.04e-05 | 191 | 139 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.04e-05 | 191 | 139 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | wk_08-11-Epithelial-PNS-KCNIP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 192 | 139 | 6 | 53642c88891f4e4e14b1740c5ced759b7d8b3572 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 3.22e-05 | 193 | 139 | 6 | bac302e69455aaaf1c18f3272bb213242664d747 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 193 | 139 | 6 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 193 | 139 | 6 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.22e-05 | 193 | 139 | 6 | 25b1e5a04724023918c8939109a92b35582d5e5c | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.32e-05 | 194 | 139 | 6 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 195 | 139 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | tumor_Lung-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 3.42e-05 | 195 | 139 | 6 | dd112ef3f8bd0790719827b6bb120918687afdff | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 195 | 139 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 139 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-05 | 196 | 139 | 6 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 139 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-05 | 197 | 139 | 6 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.62e-05 | 197 | 139 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.62e-05 | 197 | 139 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-05 | 198 | 139 | 6 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-05 | 198 | 139 | 6 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 199 | 139 | 6 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 199 | 139 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 199 | 139 | 6 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.83e-05 | 199 | 139 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.83e-05 | 199 | 139 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 200 | 139 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.93e-05 | 200 | 139 | 6 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.55e-05 | 139 | 139 | 5 | 9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.93e-05 | 144 | 139 | 5 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.53e-05 | 146 | 139 | 5 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.53e-05 | 146 | 139 | 5 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 148 | 139 | 5 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 152 | 139 | 5 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 152 | 139 | 5 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 158 | 139 | 5 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 159 | 139 | 5 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| Drug | N-succinylphenylglycine | 2.23e-07 | 3 | 139 | 3 | CID000448582 | |
| Drug | AC1MOUJL | 2.23e-07 | 3 | 139 | 3 | CID003400924 | |
| Drug | C03356 | 2.23e-07 | 3 | 139 | 3 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 2.23e-07 | 3 | 139 | 3 | CID000318915 | |
| Drug | C04309 | 2.23e-07 | 3 | 139 | 3 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 2.23e-07 | 3 | 139 | 3 | CID000192519 | |
| Drug | pefloxacin | 4.68e-07 | 26 | 139 | 5 | CID000051081 | |
| Drug | dimethyl chlorophosphate | 8.87e-07 | 4 | 139 | 3 | CID000101863 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 8.87e-07 | 4 | 139 | 3 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 8.87e-07 | 4 | 139 | 3 | CID003037152 | |
| Drug | 2-ptz | 8.87e-07 | 4 | 139 | 3 | CID000445375 | |
| Drug | tricyclohexylammonium | 8.87e-07 | 4 | 139 | 3 | CID000226271 | |
| Drug | N-methylacrylamide | 2.21e-06 | 5 | 139 | 3 | CID000014471 | |
| Drug | AC1L1CAI | 2.21e-06 | 5 | 139 | 3 | CID000000145 | |
| Drug | tartronate semialdehyde phosphate | 2.21e-06 | 5 | 139 | 3 | CID000151938 | |
| Drug | 2-phospho-3-butenoic acid | 2.21e-06 | 5 | 139 | 3 | CID000191423 | |
| Drug | 1-Pdmsp | 2.21e-06 | 5 | 139 | 3 | CID000000561 | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.24e-06 | 195 | 139 | 9 | 3001_DN | |
| Drug | dimidium | 4.39e-06 | 6 | 139 | 3 | CID000068207 | |
| Drug | Z(2-Cl)-OSu | 4.39e-06 | 6 | 139 | 3 | CID000580665 | |
| Drug | 4-(N,N-dimethylamino)cinnamoyl-CoA | 4.39e-06 | 6 | 139 | 3 | CID000445461 | |
| Drug | N-tert-butylacrylamide | 7.66e-06 | 7 | 139 | 3 | CID000007877 | |
| Drug | glycidol phosphate | 7.66e-06 | 7 | 139 | 3 | CID000152659 | |
| Drug | lavendustin C6 | 7.66e-06 | 7 | 139 | 3 | CID000126839 | |
| Drug | CPEP | 7.66e-06 | 7 | 139 | 3 | CID000360637 | |
| Drug | macrophomate | 1.22e-05 | 8 | 139 | 3 | CID010889109 | |
| Drug | magnesium | ABCC1 RAN MAT2B LAMA5 GRIK3 CPS1 ADCY8 ARF1 KRIT1 ARF3 ARF4 ARF5 NAMPT PRIM1 FLAD1 EXOC2 ENO1 ENO2 NOS1 ATP2B1 MGAT4C ENO3 | 1.74e-05 | 1325 | 139 | 22 | CID000000888 |
| Drug | AC1L19IJ | 1.82e-05 | 9 | 139 | 3 | CID000000562 | |
| Drug | AC1L1A4W | 1.82e-05 | 9 | 139 | 3 | CID000000837 | |
| Drug | cnicin | 2.15e-05 | 92 | 139 | 6 | CID000091176 | |
| Drug | pyrene-4,5-dione | 2.59e-05 | 10 | 139 | 3 | CID000160814 | |
| Drug | L-fuconic acid | 2.59e-05 | 10 | 139 | 3 | CID000345732 | |
| Drug | phosphoenolthiopyruvate | 2.59e-05 | 10 | 139 | 3 | CID000194910 | |
| Drug | xylonate | 2.59e-05 | 10 | 139 | 3 | CID000010264 | |
| Drug | reductone | 3.22e-05 | 30 | 139 | 4 | CID003034155 | |
| Drug | LG 5 | 3.29e-05 | 60 | 139 | 5 | CID011840957 | |
| Drug | AC1L1CBF | 4.25e-05 | 336 | 139 | 10 | CID000001822 | |
| Drug | citrullin | 4.39e-05 | 153 | 139 | 7 | CID000000833 | |
| Drug | LG61 | 4.71e-05 | 12 | 139 | 3 | CID000520177 | |
| Drug | AC1L18ZV | 4.71e-05 | 12 | 139 | 3 | CID000000329 | |
| Drug | Cocaine | MYOM1 VPS26B TSSK2 REL NCF4 GRIK3 ACTN2 BTBD9 NEB ADCY8 KRIT1 ARF4 KIDINS220 ABCA5 GCLM AKT1 NUP188 EXOC2 ENO2 NOS1 DNMT3B | 4.83e-05 | 1314 | 139 | 21 | ctd:D003042 |
| Drug | GTP - Na | RAN GLTP TBL1Y LAMA5 XPO1 ADCY8 ARF1 KRIT1 ARF3 CCNT2 ARRB1 KIDINS220 PRIM1 AKT1 PRKG2 EXOC2 DMD | 4.91e-05 | 923 | 139 | 17 | CID000000762 |
| Drug | I-Q-S | 4.96e-05 | 156 | 139 | 7 | CID000003540 | |
| Drug | fluoride | 5.45e-05 | 278 | 139 | 9 | CID000014917 | |
| Drug | 9-beta-D-arabinofuranosylguanine | RAB23 RAN TBL1Y REL DCX ADCY8 ARF1 KRIT1 ARF3 ARF4 ARF5 LRPAP1 AKT1 PRKG2 NOS1 MGAT4C | 5.84e-05 | 843 | 139 | 16 | CID000000765 |
| Drug | B-43 | 7.72e-05 | 14 | 139 | 3 | CID006603792 | |
| Drug | Hecameg | 7.72e-05 | 14 | 139 | 3 | CID002733955 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 8.53e-05 | 170 | 139 | 7 | 1631_UP | |
| Drug | Chlorine | 8.85e-05 | 367 | 139 | 10 | ctd:D002713 | |
| Drug | Ozone | ABCC1 KIF23 PNLIP MYOM1 SLC38A4 DCX ADCY8 ARF1 ARF3 ARF4 ARF5 NOP58 ARRB1 GCLM PRIM1 AKT1 ENO1 NOS1 ENO3 DNMT3B | 9.41e-05 | 1273 | 139 | 20 | ctd:D010126 |
| Drug | pipemidic acid | 9.60e-05 | 15 | 139 | 3 | CID000004831 | |
| Drug | 1 IN | 9.60e-05 | 15 | 139 | 3 | CID000449311 | |
| Drug | Nb d | 9.87e-05 | 174 | 139 | 7 | CID000445938 | |
| Drug | Sc 58272 | 1.11e-04 | 3 | 139 | 2 | CID000446385 | |
| Drug | 4 OM | 1.11e-04 | 3 | 139 | 2 | CID000001754 | |
| Drug | 3-deaza-2'-deoxycytidine | 1.11e-04 | 3 | 139 | 2 | CID000193661 | |
| Drug | Freon 22 | 1.18e-04 | 16 | 139 | 3 | CID000006372 | |
| Drug | guanine | RAB23 RAN OGT TBL1Y NCL DCX ADCY8 ARF1 ARF3 ARF4 ARF5 ARRB1 ARL13B LRPAP1 AKT1 ENO1 | 1.28e-04 | 902 | 139 | 16 | CID000000764 |
| Drug | 2-PE | 1.42e-04 | 17 | 139 | 3 | CID000004867 | |
| Drug | sodium tripolyphosphate | 1.49e-04 | 44 | 139 | 4 | CID000024455 | |
| Drug | norfloxacin | 1.63e-04 | 45 | 139 | 4 | CID000004539 | |
| Drug | docetaxel | 1.69e-04 | 133 | 139 | 6 | ctd:C067311 | |
| Drug | N,N-Dichlorourethane | 1.70e-04 | 18 | 139 | 3 | CID000026195 | |
| Drug | o-succinylbenzoic acid | 1.70e-04 | 18 | 139 | 3 | CID000000955 | |
| Drug | AC1L1A7Z | 1.70e-04 | 18 | 139 | 3 | CID000000874 | |
| Drug | LY294002; Up 200; 10uM; MCF7; HG-U133A | 1.70e-04 | 190 | 139 | 7 | 328_UP | |
| Drug | guanosine 5'-diphosphate disodium salt | RAN TBL1Y LAMA5 REL XPO1 ADCY8 ARF1 KRIT1 ARRB1 KIDINS220 AKT1 DMD MGAT4C | 1.74e-04 | 648 | 139 | 13 | CID000000730 |
| Drug | AC1L1GI5 | 1.94e-04 | 47 | 139 | 4 | CID000003693 | |
| Drug | purpurin-18 | 2.01e-04 | 19 | 139 | 3 | CID005489047 | |
| Drug | AC1L2YVP | 2.01e-04 | 19 | 139 | 3 | CID000080135 | |
| Drug | histidinol phosphate | 2.01e-04 | 19 | 139 | 3 | CID000000845 | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5317_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 3069_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A | 2.06e-04 | 196 | 139 | 7 | 1423_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 2.06e-04 | 196 | 139 | 7 | 1790_DN | |
| Drug | Opiate Alkaloids | 2.20e-04 | 4 | 139 | 2 | ctd:D053610 | |
| Drug | 1-cyclohexylethylamine | 2.20e-04 | 4 | 139 | 2 | CID000110733 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ABCC1 NLRP12 TBL1Y RNF17 ADCY8 KRIT1 ARRB1 LRPAP1 AKT1 PRKG2 DMD NOS1 | 2.25e-04 | 577 | 139 | 12 | CID000000295 |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 2808_UP | |
| Drug | OF L | 2.28e-04 | 49 | 139 | 4 | CID000445155 | |
| Drug | zaprinast | 2.32e-04 | 141 | 139 | 6 | CID000005722 | |
| Drug | enoxacin | 2.35e-04 | 20 | 139 | 3 | CID000003229 | |
| Disease | Colorectal Carcinoma | SHANK1 ABCC1 ANK2 CAPN6 GRIK3 ABCA10 ADCY8 NAMPT ABCA5 ACKR3 DIP2C AKT1 DMD ABCD2 | 3.70e-06 | 702 | 133 | 14 | C0009402 |
| Disease | facioscapulohumeral muscular dystrophy (is_implicated_in) | 2.02e-05 | 2 | 133 | 2 | DOID:11727 (is_implicated_in) | |
| Disease | beta-arrestin-1 measurement | 2.02e-05 | 2 | 133 | 2 | EFO_0801413 | |
| Disease | DnaJ homolog subfamily B member 14 measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0801538 | |
| Disease | Small cell carcinoma of lung | 1.05e-04 | 54 | 133 | 4 | C0149925 | |
| Disease | gamma-glutamylcitrulline measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0800690 | |
| Disease | oxidoreductase HTATIP2 measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0801863 | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 2.00e-04 | 5 | 133 | 2 | DOID:11723 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 2.71e-04 | 277 | 133 | 7 | C0009404 | |
| Disease | obsolete aging | 2.83e-04 | 279 | 133 | 7 | GO_0007568 | |
| Disease | Opioid abuse | 2.99e-04 | 6 | 133 | 2 | C0029095 | |
| Disease | Opiate Abuse | 2.99e-04 | 6 | 133 | 2 | C4551628 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 2.99e-04 | 6 | 133 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Narcotic Dependence | 2.99e-04 | 6 | 133 | 2 | C1527402 | |
| Disease | gamma-enolase measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0021845 | |
| Disease | Opiate Addiction | 2.99e-04 | 6 | 133 | 2 | C0524662 | |
| Disease | Narcotic Abuse | 2.99e-04 | 6 | 133 | 2 | C0524661 | |
| Disease | Opioid-Related Disorders | 2.99e-04 | 6 | 133 | 2 | C0027412 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.56e-04 | 74 | 133 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | ABCC1 FLNA ANK2 GRIK3 ATP8B1 ARF1 OTOGL SLC6A5 DIP2C AKT1 DMD KIT ENO1 DNMT3B | 3.61e-04 | 1074 | 133 | 14 | C0006142 |
| Disease | Periventricular Nodular Heterotopia | 4.17e-04 | 7 | 133 | 2 | C1868720 | |
| Disease | mean corpuscular hemoglobin concentration | ABCC1 BTBD9 CPS1 NEB AXIN1 ARL17A LONP1 NOP58 PRIM1 SEC16A EXOC2 ENO2 LRIF1 EPB41L2 | 4.79e-04 | 1105 | 133 | 14 | EFO_0004528 |
| Disease | cesarean section, anxiety | 5.55e-04 | 8 | 133 | 2 | EFO_0005230, EFO_0009636 | |
| Disease | serum iron measurement | 6.29e-04 | 86 | 133 | 4 | EFO_0006332 | |
| Disease | cysteine measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0021000 | |
| Disease | Non-Small Cell Lung Carcinoma | 7.23e-04 | 156 | 133 | 5 | C0007131 | |
| Disease | Adenocarcinoma of large intestine | 9.51e-04 | 96 | 133 | 4 | C1319315 | |
| Disease | Enzymopathy | 1.08e-03 | 11 | 133 | 2 | C0520572 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.26e-03 | 47 | 133 | 3 | C3179349 | |
| Disease | urinary albumin to creatinine ratio | 1.34e-03 | 179 | 133 | 5 | EFO_0007778 | |
| Disease | Gastrointestinal Stromal Tumors | 1.50e-03 | 50 | 133 | 3 | C0238198 | |
| Disease | glutaroyl carnitine measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0021005 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.68e-03 | 52 | 133 | 3 | C1168401 | |
| Disease | diacylglycerol 38:4 measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0020066 | |
| Disease | impotence (implicated_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 2.62e-03 | 17 | 133 | 2 | C0003257 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0800030 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.73e-03 | 128 | 133 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.73e-03 | 128 | 133 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.73e-03 | 128 | 133 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.73e-03 | 128 | 133 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.73e-03 | 128 | 133 | 4 | C0007134 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0010382 | |
| Disease | frontal pole volume measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0010304 | |
| Disease | diacylglycerol 38:3 measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0020065 | |
| Disease | Adenocarcinoma of prostate | 3.63e-03 | 20 | 133 | 2 | C0007112 | |
| Disease | freckles | 3.63e-03 | 20 | 133 | 2 | EFO_0003963 | |
| Disease | dentures | 3.93e-03 | 70 | 133 | 3 | EFO_0010078 | |
| Disease | dental caries, dentures | 3.93e-03 | 70 | 133 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | Psychoses, Drug | 4.00e-03 | 21 | 133 | 2 | C0033937 | |
| Disease | metabolite measurement, diet measurement | 4.09e-03 | 71 | 133 | 3 | EFO_0004725, EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKYISFCVKKGEILG | 1316 | Q8WWZ7 | |
| FGKVILVKEKATGRY | 161 | P31749 | |
| KALGSVVYVKESDGL | 71 | Q8WU43 | |
| KGISEQEGKIKTYFL | 1156 | P40145 | |
| LAARGLSSKDKYVKG | 336 | Q9BSJ8 | |
| LSSKDKYVKGLIEGK | 341 | Q9BSJ8 | |
| VGYGHLSTLVKLDKK | 676 | O60583 | |
| YIASKGVKLVSIGAE | 106 | P35609 | |
| LKELGIKVGKYVASE | 591 | Q9UBC3 | |
| VIKEYNGKTGKVEAL | 396 | Q8WWZ4 | |
| SIYVAGLDGKIVKSI | 121 | Q9UBJ2 | |
| LIEVLKGKTYSDGKN | 391 | P10323 | |
| DAAGKTTILYKLKLG | 26 | P84085 | |
| SVIVKSRGIIKSKGY | 251 | P48507 | |
| SRGIIKSKGYILQAK | 256 | P48507 | |
| KGIILAGTEEQKAKY | 151 | Q9H845 | |
| DAAGKTTILYKLKLG | 26 | P61204 | |
| DTAGKTTILYKLKLG | 26 | Q8IVW1 | |
| SAISGYGKKIDKSIK | 166 | Q3SXY8 | |
| YARKEALKGGLEKTV | 1146 | P11532 | |
| LLEGRTKELGYTVKK | 326 | P30533 | |
| TLKGVIKDKYGKDAT | 191 | P09104 | |
| VAEDGGLKKCKISSY | 16 | Q9BTE7 | |
| YKVKVKLVVSRGGLL | 321 | P49407 | |
| YRIFSKGASEIILKK | 596 | P20020 | |
| KRYKKAITLAIGDGA | 881 | O43520 | |
| TKYENGISKVGIRKL | 316 | Q9BYT9 | |
| KFGEYVDTGKLIDKI | 1011 | Q8TBY9 | |
| RETKTKAYSKEGLGL | 96 | O75175 | |
| GKTLLLAEVAKKAYG | 421 | Q9ULI1 | |
| KGIFTKDYKKTIGVD | 31 | Q9ULC3 | |
| LTGEFEKKYVATLGV | 31 | P62826 | |
| AKKIVKDVLEGYNGT | 66 | P33176 | |
| KELASKSGLKYINVG | 21 | Q9Y3D8 | |
| KGKVEKDSTGLVNYL | 1626 | Q01484 | |
| LTIGLSSVKRKKGNY | 101 | Q9UBM8 | |
| ISGTGKALAKTEKYE | 406 | Q9Y2X3 | |
| AVKYVGQLAVLKGSK | 1381 | Q15058 | |
| EEYKTFGLGLTNVKK | 971 | A0AUZ9 | |
| VKGGYTQSVKEILKR | 211 | Q9ULH0 | |
| LNLYGKTKLDGEKAV | 156 | Q9NZL9 | |
| YVLKSAELAKAGGCK | 111 | Q9BUP3 | |
| NGKVYLLAKKGTDVL | 361 | Q5T3J3 | |
| GKVVEATAYGLIKSD | 601 | P10721 | |
| GRQYLLKKKTGTIVE | 1056 | Q86WG5 | |
| RYKVSVTLSGKKVTG | 356 | P16233 | |
| KKGKFDYILLETTGL | 126 | Q8IUF1 | |
| KKGKFDYILLETTGL | 126 | Q9BRT8 | |
| IYGGDKLVSLSRKKV | 1256 | Q9NRD8 | |
| KSYTLVVAKDGGDKK | 86 | O43491 | |
| KKSEGSLAYVKGGLS | 196 | Q96KP1 | |
| VKIIVSISKGYGRAK | 1916 | Q8IVL0 | |
| VISGEALGIKSKVYT | 151 | O00625 | |
| TSKGKELVHTYKGCI | 61 | A6NC86 | |
| FVIEVKTKGGSKYLI | 41 | Q15080 | |
| YGKVEATRILLEKGK | 331 | O00522 | |
| VEKVLRKSAYKIVSG | 716 | P36776 | |
| SVRGCVKGIKALGKY | 3086 | O15230 | |
| VAKLKKSILEGTYSV | 276 | Q8IY84 | |
| YVKTSAKEGVALTKG | 256 | A6NM76 | |
| IAGKGKAILSLYVVD | 196 | O95800 | |
| IKTLQKGEYFGEKAL | 346 | Q13237 | |
| LVSKDGKSKGIAYIE | 421 | P19338 | |
| KRVKATILYATETGK | 756 | P29475 | |
| VEYLSLVKGGQDVKK | 186 | P49642 | |
| KLSDSRIALKSGYGK | 101 | Q14331 | |
| LLKTAIGKAGYTDKV | 226 | P06733 | |
| LKEYGVKVLGTSVES | 526 | P31327 | |
| KGGVTTQALAKYLKA | 266 | P07199 | |
| SGIEYTKVVKGLTKI | 721 | Q9Y2F5 | |
| YTKGAGSGELKVTVK | 506 | P21333 | |
| TLGQFKELLTKKGSY | 806 | O15169 | |
| TKEGYLTKQGGLVKT | 166 | Q9UN19 | |
| ETGVVKKLYTLDGKQ | 221 | O43602 | |
| ITQKGYEKKRSKLIG | 31 | Q9Y2E4 | |
| IFKYSAKTGLTKLID | 331 | P25106 | |
| DAAGKTTILYKLKLG | 26 | P84077 | |
| KADISGNITKIKAVY | 46 | Q9NZD2 | |
| YKIGSKKILVSLATG | 856 | Q9Y4F3 | |
| ITGEKLGELYKSFIK | 271 | P13929 | |
| AGRSKKETKYSLKAV | 271 | Q15006 | |
| SVRKELKGGKAYSKL | 86 | Q5T9C2 | |
| EKGSKLCIYALKGET | 206 | Q6SJ93 | |
| LAKQTKIEYGAVKDG | 676 | Q13003 | |
| VYKLAESGSSLGKKV | 366 | Q8NFF5 | |
| KYGAQVVKGELKSAL | 281 | Q96Q07 | |
| IDTRTVFLSKYLKKG | 451 | Q9Y6Q1 | |
| FLLGESSVEYGKKKR | 241 | Q9Y5Q0 | |
| YLSSKKIAGLTKDDG | 31 | Q9ULB4 | |
| GGTRKYAFELKEKLL | 431 | P02748 | |
| YKDGSRKLLVKAITV | 71 | Q92530 | |
| QYILVKGTGKDKFTI | 506 | Q3ZCN5 | |
| VKLGTDLEYLKKVRG | 981 | O15294 | |
| TVSSGYNTKKIGKRL | 446 | Q8TEW0 | |
| IETKLIKGDIYKTRG | 871 | Q02241 | |
| SLKAYKGLAEVAVKS | 331 | Q8WTT2 | |
| LKVLKKSAYLSAVGT | 536 | P33527 | |
| IDKYIKLVKVVSSGA | 191 | Q6NUM9 | |
| RFGGTVTEVLLKYKK | 51 | Q9NYV6 | |
| IKVATEKGASGVIIY | 116 | Q8WVZ7 | |
| KEIYLKGIAGEDTKS | 831 | Q2M3C7 | |
| KKVKRVYLFGGLGTS | 291 | Q06945 | |
| GYVSLDGKKTVKSGE | 276 | Q8N3S3 | |
| ASYLVKVGVGLESKL | 601 | Q7Z4K8 | |
| GGKVYKQATIESLKR | 21 | Q96MN5 | |
| FLKRLSKGYLVGKDS | 51 | Q8IYR2 | |
| KALAKLSSTYGKIGV | 681 | Q7LBE3 | |
| IVYASLAKGIKTSGK | 406 | Q9Y345 | |
| EYGLKKKSHGLATVR | 496 | Q2TB90 | |
| RGSGKKKDIKDLVVY | 431 | O15226 | |
| VGEKILKKYVSVCEG | 256 | A6NDU8 | |
| GKLISVEYGTEEKIK | 1531 | Q8IVG5 | |
| TKKELLGSYVKQGTE | 261 | Q8N165 | |
| TKDLSIAAVGKYGTL | 291 | O75182 | |
| KGTDTVAGLALIKKY | 216 | P43490 | |
| LLKTAKEGGSLIYEK | 126 | Q969I6 | |
| TKTGLKKFLEYVQLG | 176 | Q9Y566 | |
| YVSVLIDSAIGKTKK | 511 | Q9BVK2 | |
| DAAGKTTILYKLKLG | 26 | P18085 | |
| KGERVDVSKYLIKKG | 1086 | Q9BXT8 | |
| YDGETVSGKVSLALK | 41 | Q4G0F5 | |
| GIKKYVVGLIIKTSS | 101 | O14980 | |
| SETKKELLGTYIKQG | 456 | Q8TDR2 | |
| LVYAGIKSIVKSSLG | 451 | Q9NXC5 | |
| GVYTKKTTKLVLIGS | 1751 | O15027 | |
| GVYKSVIANKLGKAA | 1256 | Q15772 | |
| QLGKTIGEGTYSKVK | 11 | Q96PN8 | |
| IIKADVGYKGTQLKA | 96 | O75063 | |
| YKDGIVVIIDISKKG | 171 | Q8TEQ6 | |
| LRALVSGKSTAKKVY | 451 | Q5SRE5 | |
| YGKGKVRITLVTKND | 56 | Q04864 | |
| KKDGLREVGKVYISI | 221 | Q6BDI9 | |
| KKGNYVLSAGVDKTT | 286 | Q9BQ87 | |
| LGKKGKYIRLSCDTD | 111 | Q7Z2W7 | |
| YVTLTGTITRGKKKG | 101 | Q96HH4 | |
| LIAGEVGSKKYLVAA | 146 | Q92547 | |
| ILKERGGSKYEAAKK | 696 | Q92547 | |
| GKYRAECKLDTKTGL | 291 | Q96PF2 | |
| VDYLSQVGGKKEVKI | 46 | A2RUC4 | |
| KVTVLGYGLLTADAK | 126 | Q5FWF4 | |
| LAKGDSKYIEKGSPL | 656 | Q5R3F8 | |
| KKFKLYLGTATELGE | 26 | P59046 | |
| KNVYLKVRGLKEGVS | 1096 | P52179 | |
| SDKGKYTLEIAAGKE | 1286 | Q5VTT5 | |
| LSELVYRAAGKKQKS | 5156 | P20929 |